Vinyl Health raises $2M seed to put patients in charge of their records
What's the deal? Vinyl HealthDealroom has a profile for this one. Try Dealroom → has raised $2 million in seed funding led by HealthX VenturesDealroom has a profile for this one. Try Dealroom →. The New Jersey startup builds a consumer app that records doctor visits, pulls in medical records, and helps patients understand and share their care with family and providers. The money supports Vinyl's broader public launch, now live on the Google Play Store and Apple's App Store.
What's the endgame? Vinyl uses ambient AI to turn scattered health information — portals, printouts, visit summaries, family text chains — into one place patients control. With a patient's permission, it aims to surface relevant questions and flag time-sensitive options such as therapies or clinical trials.
Who's behind it? Vinyl was founded by Dr. Kaitlan Baston, a former New Jersey health commissioner and hospital chief executive officer. "Patients are expected to make important decisions about their health, but they often leave appointments or hospitalizations without a clear understanding of what happened or what to do next," she said.
Why now? Patient-facing AI notetaking is gaining ground. Kin HealthDealroom has a profile for this one. Try Dealroom → raised a larger $9 million seed in May for an app that records visits and turns them into plain-language summaries. US digital-health startups pulled in $7.4 billion in the first half of 2026, though most of that capital flowed to large enterprise and clinical rounds rather than small consumer apps.
What sets it apart? Unlike tools that summarise a single visit, Vinyl combines visit recordings with imported records and sharing across care teams and family. It also takes a privacy-forward stance: the company says its business model is not built on selling patient data.
What could go wrong? The round is modest beside the sector's biggest deals. Its payoff depends on whether Vinyl can earn patient and clinician trust, secure access to records, and show sustained use.
The signal: The $2 million raise sits in the lower tier of recent digital-health rounds — around the 33rd percentile by amount. It reflects investor appetite for consumer tools that address healthcare's fragmented records, even as most capital still chases larger clinical and enterprise plays.
Read more: markets.financialcontent.com
Image credit: Generated with Gemini
